View all trials
Are you a member? Sign in above to view additional information
  • Study title
    International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
  • Protocol ID
    rEECur; RG_13-277
  • Disease
    Disease Type Disease Subtype
    Solid tumours
    Ewings sarcoma
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Princess Margaret Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 2/3
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    03/04/2018
  • Study close date
    N/A
  • Study chair
    Marianne Phillips
  • Sponsor
    Australian and New Zealand Children's Haematology Oncology Group
Back to search results